Short-term effects of ivabradine in patients with chronic stable ischemic heart disease.

about

Short-term effects of ivabradine in patients with chronic stable ischemic heart disease.

Item

http://www.wikidata.org/entity/Q42568652

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Short-term effects of ivabradine in patients with chronic stable ischemic heart disease.

@en

Short-term effects of ivabradine in patients with chronic stable ischemic heart disease.

@nl

type

Item

label

Short-term effects of ivabradine in patients with chronic stable ischemic heart disease.

@en

Short-term effects of ivabradine in patients with chronic stable ischemic heart disease.

@nl

prefLabel

Short-term effects of ivabradine in patients with chronic stable ischemic heart disease.

@en

Short-term effects of ivabradine in patients with chronic stable ischemic heart disease.

@nl

P1476

Short-term effects of ivabradine in patients with chronic stable ischemic heart disease.

@en

P2093

Alawi A Alsheikh-Ali

http://www.w3.org/2001/XMLSchema#string

Arif Al-Mulla

http://www.w3.org/2001/XMLSchema#string

Hind Elzein

http://www.w3.org/2001/XMLSchema#string

Hosam Zaky

http://www.w3.org/2001/XMLSchema#string

P2860

European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constitute

The initial management of stable angina in Europe, from the Euro Heart Survey: a description of pharmacological management and revascularization strategies initiated within the first month of presentation to a cardiologist in the Euro Heart Survey o

Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina

Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial

Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology.

Funny channels in the control of cardiac rhythm and mode of action of selective blockers.

Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial.

Favourable long term prognosis in stable angina pectoris: an extended follow up of the angina prognosis study in Stockholm (APSIS).

Elevated heart rate: a major risk factor for cardiovascular disease.

Resting heart rate in cardiovascular disease.

P304

53-55

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/1995-705X.115495

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23983908

http://www.w3.org/2001/XMLSchema#string

P932

3752876

http://www.w3.org/2001/XMLSchema#string